Skip to main content

$440 Million Acquisition of Veterinary Pharmaceutical Company

Client

Representation of client in the acquisition of a privately-held veterinary pharmaceutical manufacturing company by a publicly-traded pharmaceutical company for $440 million of consideration consisting of stock and cash and redemption of indebtedness.

RELATED PEOPLE
David M. Seifer

David M. Seifer

Partner